Shu-Min Zhang Selected Research

Shu-Min Zhang Research Topics

Disease

7	Neointima 04/2023 - 02/2014
4	Neoplasms (Cancer) 11/2019 - 10/2004
4	Vascular System Injuries 04/2015 - 02/2014
3	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 06/2010
3	Cardiomegaly (Heart Hypertrophy) 01/2014 - 03/2013
2	Inflammation (Inflammations) 03/2022 - 02/2011
2	Human Influenza (Influenza) 09/2021 - 01/2020
2	Vascular Diseases (Vascular Disease) 10/2014 - 02/2014
1	Infections 03/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2023
1	Neoplasm Metastasis (Metastasis) 11/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2022
1	Fibrosis (Cirrhosis) 03/2022
1	Gout 10/2021
1	Arthralgia (Joint Pain) 10/2021
1	Wounds and Injuries (Trauma) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2015
1	Hyperplasia 07/2015
1	Radiation Injuries (Radiation Sickness) 01/2015
1	Carotid Artery Injuries 10/2014
1	Insulin Resistance 03/2014
1	Adenocarcinoma 12/2013
1	Carcinogenesis 03/2013
1	Infarction (Infarctions) 02/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2011
1	Reperfusion Injury 02/2011
1	Necrosis 02/2011
1	Coronary Occlusion 02/2011
1	Liver Neoplasms (Liver Cancer) 06/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2004

Drug/Important Bio-Agent (IBA)

3	gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)IBA 04/2015 - 01/2014
3	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 06/2014 - 03/2013
3	Transcription Factors (Transcription Factor)IBA 02/2014 - 03/2013
2	DiterpenesIBA 09/2021 - 01/2020
2	GlucuronidaseIBA 09/2021 - 01/2020
2	Becaplermin (PDGF-BB)FDA Link 01/2019 - 10/2014
2	myocardinIBA 02/2014 - 01/2014
2	Interferon Regulatory FactorsIBA 06/2013 - 03/2013
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 03/2013 - 02/2011
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2024
1	MethyltransferasesIBA 04/2023
1	RNA (Ribonucleic Acid)IBA 04/2023
1	8- (4- chloro- phenylthio)- 2'- O- methyladenosine- 3'- 5'- cyclic monophosphateIBA 03/2022
1	erythromycin propionate-N-acetylcysteinateIBA 03/2022
1	CytokinesIBA 03/2022
1	Uric Acid (Urate)IBA 10/2021
1	C-Reactive ProteinIBA 10/2021
1	AlkaloidsIBA 09/2021
1	Antiviral Agents (Antivirals)IBA 09/2021
1	labdaneIBA 01/2020
1	jugloneIBA 11/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	DisintegrinsIBA 01/2019
1	Bromodeoxyuridine (BrdU)IBA 01/2019
1	mindinIBA 07/2015
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2015
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2015
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2015
1	Sirtuin 1IBA 10/2014
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 10/2014
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2014
1	NF-kappaB-Inducing KinaseIBA 03/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2014
1	LipidsIBA 03/2014
1	NF-kappa B (NF-kB)IBA 03/2014
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 02/2014
1	Cysteine (L-Cysteine)FDA Link 12/2013
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	Oxidants (Oxidizing Agents)IBA 02/2011
1	AntioxidantsIBA 02/2011
1	cornusideIBA 02/2011
1	Red Fluorescent ProteinIBA 06/2010
1	Caffeine (No Doz)FDA LinkGeneric 06/2010
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2004

Therapy/Procedure

3	Therapeutics 10/2021 - 03/2013
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2023
1	Radiotherapy 11/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2021
1	Aftercare (After-Treatment) 10/2021
1	Immunotherapy 10/2004